Ghost Tree Capital’s Alnylam Pharmaceuticals ALNY Stock Holding History

Ghost Tree Capital’s Portfolio ALNY Stock Details ALNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-22,500	Closed	-$5.47M	–	56
2024 Q2	$5.47M	Sell	22,500 -37,500	-63%	-$5.92M	1.71%	24
2024 Q1	$8.97M	Buy	60,000 +32,500	+118%	+$5.42M	2.48%	11
2023 Q4	$5.26M	Buy	+27,500	New	+$4.68M	1.72%	17
2022 Q3	–	Sell	-1,900	Closed	-$277K	–	45
2022 Q2	$277K	Buy	+1,900	New	+$270K	0.14%	33
2022 Q1	–	Sell	-30,000	Closed	-$5.09M	–	44
2021 Q4	$5.09M	Buy	+30,000	New	+$5.58M	1.82%	19
2019 Q3	–	Sell	-150,000	Closed	-$10.9M	–	47
2019 Q2	$10.9M	Hold	150,000	–	–	2.26%	13
2019 Q1	$14M	Buy	150,000 +115,000	+329%	+$9.62M	3.66%	9
2018 Q4	$2.55M	Sell	35,000 -140,000	-80%	-$10.8M	0.93%	30
2018 Q3	$15.3M	Sell	175,000 -35,000	-17%	-$3.52M	3.26%	10
2018 Q2	$20.7M	Buy	+210,000	New	+$20.8M	6.09%	5
2017 Q4	–	Sell	-35,000	Closed	-$4.11M	–	51
2017 Q3	$4.11M	Buy	+35,000	New	+$2.99M	0.87%	40
2016 Q1	–	Sell	-45,000	Closed	-$4.24M	–	52
2015 Q4	$4.24M	Buy	+45,000	New	+$4.17M	1.73%	24
2015 Q3	–	Sell	-90,000	Closed	-$10M	–	78
2015 Q2	$10.8M	Buy	90,000 +50,000	+125%	+$5.98M	3.5%	5
2015 Q1	$4.18M	Sell	40,000 -15,000	-27%	-$1.52M	1.5%	25
2014 Q4	$5.33M	Buy	55,000 +20,000	+57%	+$1.85M	2.56%	11
2014 Q3	$2.73M	Sell	35,000 -40,000	-53%	-$2.58M	1.48%	31
2014 Q2	$4.74M	Buy	+75,000	New	+$4.46M	3.34%	9

Other funds holding ALNY

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Ghost Tree Capital's ALNY Position: Q3 2024 in Review

Ghost Tree Capital sold out of Alnylam Pharmaceuticals (ALNY) in Q3 2024, closing a stake of 22,500 shares — an estimated $5.47M sold.

Ghost Tree Capital first reported a position in ALNY in Q2 2014 and held it in 17 quarters. The position peaked at $20.7M in Q2 2018. 566 funds tracked by Wall St. Rank hold ALNY as of Q3 2024.

Ghost Tree Capital reported no remaining Alnylam Pharmaceuticals position as of Q3 2024 after selling out during the quarter.
Ghost Tree Capital sold 22,500 Alnylam Pharmaceuticals shares in Q3 2024, an estimated $5.47M.
Ghost Tree Capital first reported a position in Alnylam Pharmaceuticals in Q2 2014 and held it in 17 quarters.
Ghost Tree Capital's Alnylam Pharmaceuticals position peaked at $20.7M in Q2 2018.
566 funds tracked by Wall St. Rank held Alnylam Pharmaceuticals as of Q3 2024.

Based on Ghost Tree Capital's 13F filing for Q3 2024, filed 14 Nov 2024.